GlassScriptPhysician profile
Christian Koelbl
NPI 1245460526
$2,362.32
in general payments reported to CMS, 2019-2025
22 companies · $416 in 2025
The $416 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $848 · 2020: $154 · 2021: $69.81 · 2022: $193 · 2023: $76.86 · 2024: $605 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $489.31 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $488.23 | 2019-2025 | Optis |
| Cardiovascular Systems INC. | $243.34 | 2019-2022 | |
| Boston Scientific Corporation | $216.99 | 2019-2025 | Ams 800 Artificial Urinary Sphincter |
| Astrazeneca Pharmaceuticals LP | $160.61 | 2019-2020 | |
| Abiomed | $145.50 | 2019 | |
| Penumbra, INC. | $127.49 | 2025 | Penumbra System |
| Pfizer INC. | $125.31 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $54.18 | 2019-2022 | |
| Medtronic, INC. | $51.79 | 2021 | |
| Novartis Pharmaceuticals Corporation | $36.18 | 2023-2024 | |
| Terumo Medical Corporation | $33.41 | 2023 | Angio-Seal, Tr Band, Heartrail |
| Lexicon Pharmaceuticals, INC. | $25.45 | 2023 | Inpefa |
| Surmodics, INC. | $23.13 | 2022 | |
| Myriad Genetic Laboratories, INC. | $20.68 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $18.34 | 2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $18.09 | 2025 | Camzyos |
| Irhythm Technologies, INC. | $17.69 | 2024 | Zio Xt Patch, Zio Monitor |
| Sumitomo Pharma America, INC. | $17.66 | 2025 | Gemtesa |
| Exact Sciences Corporation | $17.02 | 2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $16.69 | 2025 | Arexvy, Shingrix |
| Chiesi USA, INC. | $15.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Koelbl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.